OXY
40
3
HOG
29
-4
ED
48
3
DAL
80
-4
QRVO
6
2
UPS
41
-4
TDC
75
4
CSCO
63
2
APA
21
2
AVGO
20
-5
IR
63
3
URBN
38
-4
CF
59
3
AIV
68
-4
GM
65
-3
ICE
59
-3
AXP
66
2
SIG
43
3
FOXA
55
9
XEL
67
2
OXY
40
3
HOG
29
-4
ED
48
3
DAL
80
-4
QRVO
6
2
UPS
41
-4
TDC
75
4
CSCO
63
2
APA
21
2
AVGO
20
-5
IR
63
3
URBN
38
-4
CF
59
3
AIV
68
-4
GM
65
-3
ICE
59
-3
AXP
66
2
SIG
43
3
FOXA
55
9
XEL
67
2
Financhill
Back

Relay Therapeutics Vs. Arbutus Biopharma Industry Stock Comparison

Sell
18

RLAY
Relay Therapeutics

Last Price:
4.71
Seasonality Move:
-6.4%
Sell
36

ABUS
Arbutus Biopharma

Last Price:
3.52
Seasonality Move:
15.21%
Sell
18
Relay Therapeutics (RLAY) is a Sell

Is Relay Therapeutics a Buy, Sell or Hold?

  • The current Relay Therapeutics [RLAY] share price is $4.66. The Score for RLAY is 18, which is 64% below its historic median score of 50, and infers higher risk than normal.
  • RLAY is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
36
Arbutus Biopharma (ABUS) is a Sell

Is Arbutus Biopharma a Buy, Sell or Hold?

  • The current Arbutus Biopharma [ABUS] share price is $3.44. The Score for ABUS is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.
  • ABUS is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

RLAY Stock Price Chart

What is Relay Therapeutics's stock price today?

  • The Relay Therapeutics share price today is $4.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RLAY is experiencing slight buying pressure.

ABUS Stock Price Chart

What is Arbutus Biopharma's stock price today?

  • The Arbutus Biopharma share price today is $3.44
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ABUS is experiencing selling pressure, which indicates risk of future bearish movement.

RLAY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.42 Sell
Relative Strength Index (14 RSI): 23.85 Sell
Chaikin Money Flow: 194739 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (5.35 - 6.45) Sell
Bollinger Bands (100): (5.96 - 8) Sell

ABUS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.12 Sell
Relative Strength Index (14 RSI): 28.99 Sell
Chaikin Money Flow: -417405 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (3.64 - 4.06) Sell
Bollinger Bands (100): (3.55 - 4.13) Sell

RLAY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.37 Sell
20-day SMA: 5.73 Sell
50-day SMA: 6.5 Sell
200-day SMA: 7.36 Sell
8-day EMA: 5.22 Sell
20-day EMA: 5.69 Sell
50-day EMA: 6.26 Sell
200-day EMA: 7.52 Sell

ABUS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 3.59 Sell
20-day SMA: 3.79 Sell
50-day SMA: 3.93 Sell
200-day SMA: 3.37 Buy
8-day EMA: 3.59 Sell
20-day EMA: 3.73 Sell
50-day EMA: 3.83 Sell
200-day EMA: 3.43 Buy

Relay Therapeutics Earnings Growth & RLAY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.15 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.36 per share, and a decrease next year of $0.02 per share.

Arbutus Biopharma Earnings Growth & ABUS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.01 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.06 per share, and an increase next year of $0.04 per share.

Relay Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Arbutus Biopharma Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):